Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation

Dermatology

Volumn 219, Issue 1, 2009, Pages 32-41

  Haeusermann, P ^a   Kump, E ^a   Rovo A ^a   Tichelli, A ^a   Itin, P ^a   Gratwohl, A ^a   Biedermann, B C ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b University Department of Medicine   (Switzerland)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Graft versus host disease; Long term survivors

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DENSITY; DERMIS; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MICROVASCULATURE; PRIORITY JOURNAL; RECIPIENT; SKIN BIOPSY; SKIN BLOOD VESSEL; SURVIVAL TIME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MICROVESSELS; MIDDLE AGED; SCLERODERMA, LOCALIZED; SKIN; SKIN DISEASES; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 67651083456     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000216934     Document Type: Article

References (23)

1. Sullivan KM: Graft-versus-host disease;in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Cambridge, Blackwell Scientific, 1994, pp 339-362.
2. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R: Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997;54:131-138. (Pubitemid 27079419)
3. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP: Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999;341:14-21.
4. Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM, Maris MB, Storb R: Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003;102:756-762. (Pubitemid 36842003)
5. Deeg HJ, Spitzer TR, Cottler-Fox M, Cahill R, Pickle LW: Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant 1991;7:193-198.
6. Weisdorf DJ: Chronic graft-versus-host disease: where is promise for the future? Leukemia 2005;19:1532-1535.
7. Hausermann P, Walter RB, Halter J, Biedermann BC, Tichelli A, Itin P, Gratwohl A: Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology 2008;216:287-304. (Pubitemid 351630093)
8. Ferrara JLM, Cooke KR, Teshima T: The pathophysiology of graft-versus-host disease; in Ferrara JLM, Cooke KR, Deeg HJ (eds): Graft-versus-Host Disease. New York, Dekker, 2005, pp 1-34.
9. Hofmeister CC, Quinn A, Cooke KR, Stiff P, Nickoloff B, Ferrara JL: Graft-versus-host disease of the skin: life and death on the epidermal edge. Biol Blood Marrow Transplant 2004;10:366-372. (Pubitemid 38647285)
10. Cutler C, Antin JH: Chronic graft-versus-host disease. Curr Opin Oncol 2006;18:126-131.
11. Sullivan KM: Graft-versus-host disease; in Blume KG, Forman SJ, Appelbaum FR (eds): Thomas' Hematopoietic Cell Transplantation, ed 3. Malden, Blackwell Publishing, 2004, pp 635-664.
12. Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB: Scleroderma, Sjogren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med 1977;87:707-709.
13. Gratwhol AA, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB, Deisseroth AB: Sjogren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med 1977;87:703-706.
14. Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS, Gratwohl A: Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 2002;359:2078-2083. (Pubitemid 34680972)
15. Blann AD, Taberner DA: A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995;90:244-248.
16. Kowalewski C, Kozlowska A, Gorska M, Wozniak K, Krajewski M, Blaszczyk M, Jablonska S: Alterations of basement membrane zone and cutaneous microvasculature in morphea and extragenital lichen sclerosus. Am J Dermatopathol 2005;27:489-496. (Pubitemid 44383992)
17. Braverman IM: Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. J Invest Dermatol 1989;93:2S-9S.
18. Braverman IM: The cutaneous microcirculation: ultrastructure and microanatomical organization. Microcirculation 1997;4:329-340.
19. Braverman IM: The cutaneous microcirculation. J Investig Dermatol Symp Proc 2000;5:3-9.
20. Smith EA, LeRoy EC: A possible role for transforming growth factor-beta in systemic sclerosis. J Invest Dermatol 1990;95:125S-127S.
21. Sapadin AN, Esser AC, Fleischmajer R: Immunopathogenesis of scleroderma - Evolving concepts. Mt Sinai J Med 2001;68:233-242.
22. Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M, Halter J, Meyer-Monard S, Heim D, Tsakiris DA, Biedermann B, Passweg JR, Gratwohl A: Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 2007;110:3463-3471. (Pubitemid 350106343)
23. Basavaraju SR, Easterly CE: Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002;29:2391-2403.